Author Archives: JAIDS

HIV stigma trends in the general population during antiretroviral treatment expansion: …

Background: HIV-related stigma is associated with increased risk-taking behavior, reduced uptake of HIV testing, and decreased adherence to antiretroviral therapy (ART).

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged , | Comments closed

HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy

Objective: Combination antiretroviral therapy (ART) decreases the risk of sexual HIV transmission by suppressing blood and genital HIV RNA concentrations.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged , | Comments closed

Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for…

Background: Tuberculosis (TB) risk and mortality increase in the 6 months after highly active antiretroviral therapy (HAART) initiation.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged , | Comments closed

Impact of Peer Support on Behavior Change Among Newly Diagnosed Australian Gay Men

Introduction: Treatment as prevention relies on early uptake of HIV treatment, but onward transmission during primary HIV infection may be affected by changes in sexual risk behavior after diagnosis.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

Persons Living With HIV in the United States: Fewer Than We Thought

Objectives: To estimate the number of persons living with HIV (PLWH) in the United States and to describe their care status.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

Diagnosis and Disclosure of HIV Status: Implications for Women’s Risk of Physical Partner…

Introduction: This study prospectively examined whether HIV leads to elevated risk for intimate partner violence (IPV) for women and how this risk varies depending on HIV status disclosure to a partner.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

Brief Report: Apparent Antiretroviral Overadherence by Pill Count is Associated With HIV…

Abstract: Pill counts with calculated adherence percentages are used in many settings to monitor adherence, but can be undermined by patients discarding pills to hide nonadherence.

Posted in Journal Watch | Comments closed

Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy…

Background: The uptake of intensified active TB case-finding among HIV-infected patients using symptom screening is not well understood.

Posted in Journal Watch | Comments closed

Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San…

Objectives: To perform geriatric assessments in older HIV-infected adults in San Francisco and examine the association with age and the Veterans Aging Cohort Study (VACS) index scores.

Posted in Journal Watch | Comments closed

Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis

Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers.

Posted in Journal Watch | Comments closed

Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide…

Objective: To evaluate the quantification performance of the new Cepheid GeneXpert HIV-1 viral load assay, on a wide panel of HIV-1 variants.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

Fracture Prediction With Modified-FRAX in Older HIV-Infected and Uninfected Men

Background: FRAX is a validated, computer-based clinical fracture risk calculator that estimates the 10-year risk of major osteoporotic (clinical spine, forearm, hip, or shoulder) fracture, and hip fracture alone.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl…

Background: We report the pharmacokinetic interactions of combined oral contraceptive (COC) containing ethinyl estradiol (EE2)/desogestrel (DSG) with lopinavir/ritonavir (LPV/r) in 16 HIV-positive adolescents.

Posted in Journal Watch | Comments closed

Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: …

Background: Quantifying tissue drug concentrations can yield important information during drug development, but complicates pharmacokinetic study design.

Posted in Journal Watch | Comments closed